Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab for Exercise-Induced Bronchoconstriction in Asthma
NCT03327701Phase 3Unknown
- Sponsor
- Louis-Philippe Boulet
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of benralizumab in Exercise-induced bronchoconstriction (EIB), asthma, sponsored by Louis-Philippe Boulet. Status: unknown.
02
Drugs
benralizumab
03
Conditions
Exercise-induced bronchoconstriction (EIB)asthma
Beyond the preview
Go deeper on NCT03327701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03327701.